Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
NCT00103753
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Beta-Thalassemia
Interventions
DRUG:
deferiprone
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]